Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight
NCT06858878
Original registry description
The primary objective of this study is to demonstrate that maridebart cafraglutide is superior to placebo for percent change in body weight.